Longeveron Inc. (LGVN)
NASDAQ·Healthcare·Biotechnology
$0.88
-1.77%
Mkt Cap $20.97M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+1031.1%
Consensus $10.00 vs current $0.88
NASDAQ·Healthcare·Biotechnology
$0.88
-1.77%
Mkt Cap $20.97M
No recent rating data.
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
+1031.1%
Consensus $10.00 vs current $0.88